Sumitomo Dainippon Pharma

Osaka, Japan Founded: 1897 • Age: 129 yrs Listed
Pharmaceuticals, food ingredients, additives, and veterinary products are manufactured.

About Sumitomo Dainippon Pharma

Sumitomo Dainippon Pharma is a publicly listed company based in Osaka (Japan) founded in 1897. Pharmaceuticals, food ingredients, additives, and veterinary products are manufactured. Sumitomo Dainippon Pharma has completed 4 acquisitions, including Boston Biomedical, Sepracor and Sunovion. Its focus areas include Life Sciences, Immunotherapy, Small Molecule and Immunosuppressive Pathway Inhibitors.

Company details

Sumitomo Dainippon Pharma was founded in 1897 and is headquartered in Osaka, Japan. Operations focus on the pharmaceutical sector, where 11 products are developed for therapeutic areas including hypertension, Parkinsons disease, and antifungal treatments. Additional activities encompass the production of food ingredients, food additives, and veterinary products, supporting diverse markets in healthcare and nutrition.

  • Headquarters Osaka, Japan
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website ds-pharma.com
  • Social LinkedIn
Key Metrics

People of Sumitomo Dainippon Pharma

21 people are tracked at Sumitomo Dainippon Pharma (7 in leadership, 10 in board & advisors, 4 in team).

NameRoleGroup
Hitoshi Odagiri
Representative Director & Executive Vice President, Sales & Marketing DivisionLeadership
Hiroshi Nomura
Representative Director, President & CEOLeadership
Yoshiharu Ikeda
Director & Senior Executive Officer, Regulatory & Medical AffairsLeadership
Toru Kimura
Representative Director, Executive Vice President & Chief Scientific OfficerLeadership
Jessica Lu
Marketing DirectorLeadership
Debra Phillips
Director, Clinical DevelopmentLeadership
Paul Meringolo
Director - Human ResourcesLeadership
Junsuke Fujii
Outside Audit & Supervisory Board MemberBoard & advisors
Minoru Usui
Outside Board MemberBoard & advisors
Nobuhiko Endo
Outside Board MemberBoard & advisors
Takashi Kutsunai
Audit & Supervisory Board MemberBoard & advisors
Masayo Tada
ChairmanBoard & advisors
Yutaka Atomi
Outside Board MemberBoard & advisors
Mayumi Mochizuki
Outside Audit & Supervisory Board MemberBoard & advisors
Yoshinori Oh-e
Audit & Supervisory Board MemberBoard & advisors
Saeko Arai
Outside Board MemberBoard & advisors
Yoshio Iteya
Outside Audit & Supervisory Board MemberBoard & advisors
Yudai Furuta
Research ScientistTeam
Lisa Haase
Office ManagerTeam
Nishinaka Shigeyuki
Senior Executive OfficerTeam

1 more people are available in the full profile.

Premium access

Complete people profiles for Sumitomo Dainippon Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sumitomo Dainippon Pharma

Sumitomo Dainippon Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Boston Biomedical, Sepracor and Sunovion.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Pharmaceutical company that specializes in treatment of CNS and respiratory ailments
sunovion.comMarlborough, United States1984Aug 2021β€’β€’β€’β€’
Therapeutics for cancer and blood disorders are developed.
toleropharma.comLehi, United States2011Dec 2016$780M
Develops novel therapeutics for treatment of cancer
bostonbiomedical.comBoston, United States2006Feb 2012$200M
Pharmaceutical products for respiratory and CNS disorders are developed.
sepracor.comMarlborough, United States1984Sep 2009$2.6B
Premium access

Complete acquisition details for Sumitomo Dainippon Pharma

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Sumitomo Dainippon Pharma

5 dated milestones of Sumitomo Dainippon Pharma across 124 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sumitomo Dainippon Pharma is founded.
  2. Acquisition Acquires Sepracor.
  3. Acquisition Acquires Boston Biomedical.
  4. Acquisition Acquires Tolero Pharma.
  5. Acquisition Acquires Sunovion.

Web traffic of Sumitomo Dainippon Pharma

Websites that share an audience with Sumitomo Dainippon Pharma (ds-pharma.com).

Similar websites

Websites whose visitors overlap most with Sumitomo Dainippon Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
abiogen.it
100%
#1,682,569View details
ir.horizon-pharma.com
ir.horizon-pharma.com
99%
–
antarespharma.com
98%
View details
bostonbiomedical.com
97%
View details
daiichisankyo.com
96%
72.3K#682,883View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 13 similar websites and full traffic analytics for Sumitomo Dainippon Pharma

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sumitomo Dainippon Pharma

Premium access

Complete news archive for Sumitomo Dainippon Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumitomo Dainippon Pharma

Sumitomo Dainippon Pharma was founded in 1897.

Sumitomo Dainippon Pharma is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.

Sumitomo Dainippon Pharma was founded in 1897 and is headquartered in Osaka, Japan. Operations focus on the pharmaceutical sector, where 11 products are developed for therapeutic areas including hypertension, Parkinsons disease, and antifungal treatments. Additional activities encompass the production of food ingredients, food additives, and veterinary products, supporting diverse markets in healthcare and nutrition.

Sumitomo Dainippon Pharma has made 4 acquisitions, including Boston Biomedical, Sepracor, and Sunovion.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available